Long Ideas - Shares of Endo Pharmaceuticals (NASDAQ:ENDP) are trading at a deep discount to other pharmaceutical companies, with the last dip in price coming on the heels … Continue Reading
Read nowLong Ideas - Endo Pharmaceuticals (NASDAQ:ENDP) is hosting its analyst day today in NY, and despite guiding for lower 2013 revenues and EPS compared to Wall Street Consensus … Continue Reading
Read nowMost Popular - Peregrine Pharmaceuticals (NASDAQ:PPHM) could have big trouble after reporting erroneous clinical trial results that took the stock up 13-fold from its lows this year. Lawsuits … Continue Reading
Read nowLong Ideas - Merge Healthcare (NASDAQ:MRGE) fell hard earlier this year when the company announced changes to its business model. In particular, the company moved to offer subscription-based … Continue Reading
Read nowResearch - Short interest in ResMed Inc. (NYSE:RMD) is at its highest point this year, signaling that investors are growing increasingly bearish on the company’s valuation and … Continue Reading
Read now